This website uses cookies to ensure you get the best experience on our website.
Privacy Policy
I Agree
UroToday
Contact
Login
Sign Up Free
Transformative Evidence
mCRPC
The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
PROfound
VISION Trial
mHSPC
ARASENS Trial
nmCRPC
ARAMIS Trial
nmCSPC
EMBARK Trial
PSMA PET Imaging
CONDOR Trial
OSPREY Trial
Bladder Cancer
Bladder Cancer Detection
ADSTILADRIN
Trials in Progress
Trials in Progress
Bladder Cancer
IMMORTAL
PIVOT-006
Kidney Cancer
RadiCal
SAMURAI
Middle Side
Prostate Cancer
ARAMON
ARASEC
ARASTEP
ECLIPSE
ESCAPE
FORT
NRG-GU 0101
Masofaniten (EPI-7386)
METANOVA
RTIRE
SHORTER
Right Side
PCCTC
DORA
IRONMAN
PROMISE
Centers of Excellence
Urologic Oncology
Left Group
Health Policy
Health Policy
Ruchika Talwar, MD
Bladder Cancer
Bladder Cancer
Ashish Kamat, MD
Advanced Bladder Cancer
Petros Grivas, MD
Trimodality Therapy
Leslie Ballas, MD
Kidney Cancer
Advanced Kidney Cancer
Pedro Barata, MD, MSc
Endourology
Endourology
Sumanta (Monty) Kumar Pal, MD
Jaime Landman, MD
Prostate Cancer
Advanced Prostate Cancer
Alicia Morgans, MD, MPH
CRPC with Bone Metastases
Rana R. McKay, MD
Imaging Center
Phillip Koo, MD
Localized Prostate Cancer
Matthew R. Cooperberg, MD, MPH
mHSPC
Alicia Morgans, MD, MPH
nmCRPC
Alicia Morgans, MD, MPH
PSMA-Targeted Therapy
Disparities: Social Determinants of Health
Disparities: Social Determinants of Health
Samuel L. Washington III, MD, MAS
Translational Prostate Cancer
Translational Science in Prostate Cancer
Andrea Miyahira, Ph.D
Women in Science
Andrea Miyahira, Ph.D
Upper Tract Urothelial Carcinoma
Upper Tract Urothelial Carcinoma
Sam S. Chang, MD, MBA
TESTICULAR, PENILE & RARE GU MALIGNANCIES
Testicular, Penile, and Rare GU Malignancies
Pelvic Health & Reconstruction
Bladder Health
Diane K. Newman, DNP, ANP-BC, FAAN
Pelvic Health
Diane K. Newman, DNP, ANP-BC, FAAN
Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
Stephen R. Kraus, MD
Urologic Catheters (Includes CAUTI)
Diane K. Newman, DNP, ANP-BC, FAAN
Videos
Exclusives
Conferences
Exclusive Collaborations
Independent Medical Education
Covid-19
The Prostate Cancer Foundation
Health Policy in Urological Diseases
Disparities: Social Determinants of Health
Practice Guidelines Reviews
Urologic Oncology
Prostate Cancer
Bladder Cancer
Kidney Cancer
Upper Tract Urothelial Tumors
Testicular Cancer
Endourology
Pelvic Health & Reconstruction
Pelvic Health & Reconstruction
Clinical Trials
From the Editor
Search Clinical Trials
Articles
Urology (benign and malignant)
Urologic Oncology
Men's Health
Endourology & Stones
Pediatric Urology
COVID-19 and Genitourinary Cancers
Pelvic Health
Pelvic Health & Reconstruction
Conference Coverage
Recent Conferences
SESAUA 2024
Southern CA GU Cancer Research Forum 2024
AUA Urology Advocacy Summit 2024
ASCO GU 2024
2024 UCSF-UCLA PSMA Conference
SUO 2023
All Conferences
View All
PCF
UroToday Home
Conference Highlights
ASCO GU 2019
ASCO GU 2019 Prostate Cancer
ASCO GU 2019
Prostate Cancer
Kidney Cancer
Bladder Cancer
Penile, Urethral, Testicular, and Adrenal Cancers
Press Releases
ASCO GU 2019 Prostate Cancer
Viewing 141-160 of 10957 articles
ASCO GU 2024: Updated Results from AVENANCE: Real-World Effectiveness of Avelumab First-Line Maintenance in Patients with Advanced Urothelial Carcinoma and Analysis of Subsequent Treatment
ASCO GU 2024: Defining Molecular Features Associated with Microsatellite Instability and Response to Immune Checkpoint Blockade in Urothelial Carcinoma
ASCO GU 2024: FGFR3 Mutated Urothelial Carcinoma of Bladder or Upper Tract: A Comparative Genomic Landscape Study
ASCO GU 2024: Oral APL-1202 in Combination with Tislelizumab as Neoadjuvant Therapy in Patients with MIBC: Interim Analysis of ANTICIPATE Phase II Trial
ASCO GU 2024: Urachal and Non-urachal Adenocarcinomas of the Bladder: A Comparative Comprehensive Genomic Profiling Study
ASCO GU 2024: Predictive Value of Dynamic Changes in ctDNA and Baseline Biomarkers with Neoadjuvant Atezolizumab in Operable Urothelial Carcinoma in the ABACUS Trial
ASCO GU 2024: Safety and Efficacy of Enfortumab Vedotin in Patients with Metastatic/locally Advanced Urothelial Cancer: Real-World Evidence from a European Database
ASCO GU 2024: Optimizing Treatment Strategies for Patients with Positive Pelvic/Retroperitoneal Lymph Nodes – Complete Clinical Response: Now What?
ASCO GU 2024: Outcomes in Patients with Advanced Urothelial Carcinoma Treated with Enfortumab Vedotin After Switch Maintenance Avelumab in the UNITE Study
ASCO GU 2024: HER2 and PD-L1 Immunohistochemistry Expression, and HER2 Genomic Alterations: Associations and Clinical Outcomes for Advanced Bladder Cancer
ASCO GU 2024: A Phase 2 Single-Arm Study Testing SBRT, Adenosine Signaling Modulation, and Immune Checkpoint Inhibition for Men with Hormone-Sensitive Oligometastatic Prostate Cancer (SBRT-AMICO)
ASCO GU 2024: Apalutamide plus Intermittent Versus Continuous Androgen-Deprivation Therapy in Participants with Metastatic Castration-Sensitive Prostate Cancer: LIBERTAS Phase 3 Study Design
ASCO GU 2024: Salvage Radiotherapy Options for Biochemical Recurrence After Local Treatment
ASCO GU 2024: A Phase 1/2 Study of ONCT-534, a Dual-Action Androgen Receptor Inhibitor in Patients with Metastatic Castration-Resistant Prostate Cancer
ASCO GU 2024: Apalutamide and Stereotactic Body Radiation Therapy for Low-Burden, Metastatic, Hormone-Sensitive Prostate Cancer: A Randomized Trial (PERSIAN)
ASCO GU 2024: EORTC GUCG 2238 De-Escalate: A Pragmatic Trial to Revisit Intermittent Androgen-Deprivation Therapy in Metastatic Hormone-Naïve Prostate Cancer in the Era of New AR Pathway Inhibitors
ASCO GU 2024: COMBAT: A Study of 64Cu-SAR-BBN and 67Cu-SAR-BBN for Identification and Treatment of GRPr-Expressing Metastatic Castrate-Resistant Prostate Cancer
ASCO GU 2024: Impact of Race on Outcomes to 177-Lu-PSMA-617 for mCRPC
ASCO GU 2024: Remote Delivery of Cancer Genetic Testing in Veterans with Metastatic Prostate Cancer: A Million Veteran Program Study
ASCO GU 2024: Real-Life Data on [177Lu]Lu-PSMA-617: Descriptive Analysis on the Largest mCRPC Cohort Treated in France
3
4
5
6
7
8
9
10
11
12
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free